Hostname: page-component-7c8c6479df-xxrs7 Total loading time: 0 Render date: 2024-03-29T00:26:00.076Z Has data issue: false hasContentIssue false

Afferent signals regulating food intake

Published online by Cambridge University Press:  28 February 2007

George A. Bray
Affiliation:
Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, Louisiana 70808, USA
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Food intake is a regulated system. Afferent signals provide information to the central nervous system, which is the centre for the control of satiety or food seeking. Such signals can begin even before food is ingested through visual, auditory and olfactory stimuli. One of the recent interesting findings is the demonstration that there are selective fatty acid taste receptors on the tongue of rodents. The suppression of food intake by essential fatty acids infused into the stomach and the suppression of electrical signals in taste buds reflect activation of a K rectifier channel (K 1.5). In animals that become fat eating a high-fat diet the suppression of this current by linoleic acid is less than that in animals that are resistant to obesity induced by dietary fat. Inhibition of fatty acid oxidation with either mercaptoacetate (which blocks acetyl-CoA dehydrogenase) or methyl­palmoxirate will increase food intake. When animals have a choice of food, mercaptoacetate stimulates the intake of protein and carbohydrate, but not fat. Afferent gut signals also signal satiety. The first of these gut signals to be identified was cholecystokinin (CCK). When CCK acts on CCK-A receptors in the gastrointestinal tract, food intake is suppressed. These signals are transmitted by the vagus nerve to the nucleus tractus solitarius and thence to higher centres including the lateral parabrachial nucleus, amygdala, and other sites. Rats that lack the CCK-A receptor become obese, but transgenic mice lacking CCK-A receptors do not become obese. CCK inhibits food intake in human subjects. Enterostatin, the pentapeptide produced when pancreatic colipase is cleaved in the gut, has been shown to reduce food intake. This peptide differs in its action from CCK by selectively reducing fat intake. Enterostatin reduces hunger ratings in human subjects. Bombesin and its human analogue, gastrin inhibitory peptide (also gastrin-insulin peptide), reduce food intake in obese and lean subjects. Animals lacking bombesin-3 receptor become obese, suggesting that this peptide may also be important. Circulating glucose concentrations show a dip before the onset of most meals in human subjects and rodents. When the glucose dip is prevented, the next meal is delayed. The dip in glucose is preceded by a rise in insulin, and stimulating insulin release will decrease circulating glucose and lead to food intake. Pyruvate and lactate inhibit food intake differently in animals that become obese compared with lean animals. Leptin released from fat cells is an important peripheral signal from fat stores which modulates food intake. Leptin deficiency or leptin receptor defects produce massive obesity. This peptide signals a variety of central mechanisms by acting on receptors in the arcuate nucleus and hypothalamus. Pancreatic hormones including glucagon, amylin and pancreatic polypeptide reduce food intake. Four pituitary peptides also modify food intake. Vasopressin decreases feeding. In contrast, injections of desacetyl melanocyte-stimulating hormone, growth hormone and prolactin are associated with increased food intake. Finally, there are a group of miscellaneous peptides that modulate feeding. β-Casomorphin, a heptapeptide produced during the hydrolysis of casein, stimulates food intake in experimental animals. In contrast, the other peptides in this group, including calcitonin, apolipoprotein A-IV, the cyclized form of histidyl-proline, several cytokines and thyrotropin-releasing hormone, all decrease food intake. Many of these peptides act on gastrointestinal or hepatic receptors that relay messages to the brain via the afferent vagus nerve. As a group they provide a number of leads for potential drug development.

Type
3rd Plenary Session on ‘Signalling in body-weight homeostasis’
Copyright
Copyright © The Nutrition Society 2000

References

Alemzadeh, R, Jacobs, W & Pitukcheewanont, P (1996) Antiobesity effect of diazoxide in obese Zucker rats. Metabolism 45, 334341.CrossRefGoogle ScholarPubMed
ALS CNTF Treatment Study Group (1996) A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis. Neurology 46, 12441249.CrossRefGoogle Scholar
Arase, K, Fisler, JS, Shargill, NS, York, DA & Bray, GA (1988) Intracerebroventricular infusions of 3-OHB and insulin in a rat model of dietary obesity. American Journal of Physiology 255, R974-R981.Google Scholar
Baile, CA & Della-Fera, MA (1984) Peptidergic control of food intake in food-producing animals. Federation Proceedings 43, 28982902.Google ScholarPubMed
Barton, C, York, DA & Bray, GA (1995) Bombesin-induced hypothermia in rats tested at normal ambient temperatures. Contribution of the sympathetic nervous system. Brain Research Bulletin 37, 163168.CrossRefGoogle ScholarPubMed
Blundell, JE, Lawton, CL & Halford, JCG (1995) Serotonin, eating behavior, and fat intake. Obesity Research 3, 471476.CrossRefGoogle ScholarPubMed
Boosalis, MG, Gemayel, N, Lee, A, Bray, GA, Laine, L & Cohen, H (1992) Cholecystokinin and the satiety: Effect of hypothalamic obesity and gastric bubble insertion. American Journal of Physiology 262, R241-R244.Google ScholarPubMed
Bray, GA (1995) Nutrient intake is modulated by peripheral peptide administration. Obesity Research 3, Suppl. 4, 569S572S.CrossRefGoogle ScholarPubMed
Bray, GA (1996a) Leptin and leptomania. Lancet 348, 140141.CrossRefGoogle Scholar
Bray, GA (1996b) What's in a name: The glucostatic or glucodynamic hypothesis for regulation of food intake. Obesity Research 4, 489492.CrossRefGoogle Scholar
Bray, GA & York, DA (1971) Genetically transmitted obesity in rodents. Physiological Reviews 51, 598646.CrossRefGoogle ScholarPubMed
Bray, GA & York, DA (1972) Studies on food intake of genetically obese rats. American Journal of Physiology 223, 176179.CrossRefGoogle ScholarPubMed
Bray, GA & York, DA (1979) Hypothalamic and genetic obesity in experimental animals: an autonomic and endocrine hypothesis. Physiological Reviews 59, 719809.CrossRefGoogle ScholarPubMed
Brief, DJ & Davis, JD (1984) Reduction of food intake and body weight by chronic intraventricular insulin infusion. Brain Research Bulletin 12, 571575.CrossRefGoogle ScholarPubMed
Campfield, LA, Smith, FJ, Guisez, Y, Devoa, R & Burn, P (1995a) Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 269, 546549.CrossRefGoogle ScholarPubMed
Campfield, LA, Smith, FJ, Mackie, G, Tenenbaum, R, Sassano, ML, Mullin, J, Kaiser, K & Kierstead, RW (1995b) Insulin normalization as an approach to the pharmacological treatment of obesity. Obesity Research 3, S591S603.CrossRefGoogle Scholar
Campfield, LA, Smith, FJ, Rosenbaum, M & Hirsch, J (1996) Human eating: evidence for a physiological basis using a modified paradigm. Neuroscience and Biobehavior Reviews 20, 133137.CrossRefGoogle ScholarPubMed
Cangiano, C, Ceci, F, Cascino, A, Del Ben, M, Laviano, A, Muscaritoli, M, Antonucci, F & Rossi-Fanelli, F (1992) Eating behavior and adherence to dietary prescriptions in obese adult subjects treated with 5-hydroxytryptophan. American Journal of Clinical Nutrition 56, 863867.CrossRefGoogle ScholarPubMed
Castillo, MJ, Scheen, AJ & Lefebvre, PJ (1995) Amylin/islet amyloid polypeptide: biochemistry, physiology, path-physiology. Diabetes and Metabolism 21, 325.Google Scholar
Chance, WT, Balasubramaniam, A, Stallion, A & Fischer, JE (1993) Anorexia following the systemic injection of amylin. Brain Research 607, 185188.CrossRefGoogle ScholarPubMed
Chance, WT, Balasubramaniam, A, Zhang, FS, Wimalawansa, SJ & Fischer, JE (1991) Anorexia following the intrahypothalamic administration of amylin. Brain Research 539, 352354.CrossRefGoogle ScholarPubMed
Clement, K, Vaisse, C & Lahlou, N (1998) A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 392, 398401.CrossRefGoogle ScholarPubMed
Cokelaere, MM, Busselen, P, Flo, G, Daenens, P, Decuypere, E, Kuhn, E & Van Boven, M (1995) Devazepide reverse the anorexic effect of simmondsin in the rat. Journal of Endocrinology 147, 473477.CrossRefGoogle ScholarPubMed
Cokelaere, MM, Dangreau, HD, Arnouts, S, Kuhn, ER & Decuypere, EMP (1992) Influence of pure simmondsin on food intake in rats. Journal of Agricultural and Food Chemistry 40, 18391842.CrossRefGoogle Scholar
Corwin, RL, Gibbs, J & Smith, GP (1991) Increased food intake after type A but not type B cholecystokinin receptor blockade. Physiology and Behavior 50, 255258.CrossRefGoogle Scholar
Crawley, JN & Corwin, RL (1994) Biological actions of cholecystokinin. Peptides 15, 731755.CrossRefGoogle ScholarPubMed
Diabetes Care and Complications Trial (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine 329, 977986.CrossRefGoogle Scholar
Erlanson-Albertsson, C, Mei, J, Okada, S, York, DA & Bray, GA (1991) Pancreatic procolipase propeptide, enterostatin, specifically inhibits fat intake. Physiology and Behavior 49, 11911194.CrossRefGoogle ScholarPubMed
Erlanson-Albertsson, C & York, D (1997) Enterostatin – A peptide regulating fat intake. Obesity Research 5, 360372.CrossRefGoogle ScholarPubMed
Esler, MD, Turner, AG, Kaye, DM, Thompson, JM, Kingwell, BA, Morris, M, Lambert, GW, Jennings, GL, Cox, HS & Seals, DR (1995) Aging effects on human sympathetic neuronal function. American Journal of Physiology 269, R278R282.Google Scholar
Farooqi, IS, Jebb, SA, Langmark, G, Lawrence, E, Cheetham, CH, Prentice, AM, Hughes, IA, McCarnish, MA & O'Rahilly, S (1999) Effects of recombinant leptin therapy in a child with congenital leptin deficiency. New England Journal of Medicine 341, 879884.CrossRefGoogle Scholar
Fisler, JS, Shimizu, H & Bray, GA (1989) Brain 3-hydroxybutyrate, and GABA in a rat model of dietary obesity. Physiology and Behavior 45, 571577.CrossRefGoogle Scholar
Flier, JS (1998) Clinical review 94: What's in a name? In search of leptin's physiologic role. Journal of Clinical Endocrinology and Metabolism 83, 14071413.Google Scholar
Flint, A, Raben, A, Astrup, A & Holst, JJ (1998) Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. Journal of Clinical Investigation 101, 515520.CrossRefGoogle ScholarPubMed
Friedman, MI (1995) Control of energy intake by energy metabolism. American Journal of Clinical Nutrition 62, 1096S1100S.CrossRefGoogle ScholarPubMed
Fujimoto, K, Machidori, H, Iwakiri, R, Yamamoto, K, Fujisaki, J & Tso, P (1993) Effect of intravenous administration of apolipoprotein A-IV on patterns of feeding, drinking and ambulatory activity of rats. Brain Research 608, 233237.CrossRefGoogle ScholarPubMed
Fujimoto, K, Sakata, T, Shiraishi, T, Kurata, K, Terada, K & Etou, H (1986) Anorexia induced in rat by D-glucosamine deoxidized at C-1. American Journal of Physiology 251, R481-R491.Google ScholarPubMed
Fukuda, A, Oomura, Y, Plata-Salaman, CR, Minami, T & Ito, C (1988) A novel endogenous sugar acid depolarizes ventromedial hypothalamic neurons in vitro. American Journal of Physiology 255, R134-R140.Google ScholarPubMed
Geary, N (1990) Pancreatic glucagon signals postprandial satiety. Neuroscience and Biobehavioral Reviews 14, 323338.CrossRefGoogle ScholarPubMed
Geary, N, Kissilef, HR, Pi-Sunyer, FX & Hinton, V (1992) Individual, but not simultaneous, glucagon and cholecystokinin infusions inhibit feeding in men. American Journal of Physiology 262, R975-R980.Google Scholar
Geary, N & Smith, G (1983) Selective hepatic vagotomy blocks pancreatic glucagon's satiety effect. Physiology and Behavior 31, 391394.CrossRefGoogle ScholarPubMed
Gerardo-Gettens, T, Moore, BJ, Stern, JS & Horwitz, BA (1989) Prolactin stimulates food intake in the absence of ovarian progesterone. American Journal of Physiology 256, R701R706.Google ScholarPubMed
Gibbs, J, Fauser, D, Rowe, E, Rolls, B, Rolls, E & Madison, S (1979) Bombesin suppresses feeding in rats. Nature 282, 208210.CrossRefGoogle ScholarPubMed
Gibbs, J & Smith, GP (1998) Peptides of digestive system and brain. Model of the cholecystokinin system. Annals of Endocrinology 49, 113120.Google Scholar
Gibbs, J, Young, RC & Smith, GP (1973) Cholecystokinin decreases food intake in rats. Journal of Comparative Physiology and Psychology 84, 488495.CrossRefGoogle ScholarPubMed
Gilbertson, TA, Liu, L, York, DA & Bray, GA (1998) Dietary fat preferences are inversely correlated with peripheral gustatory fatty acid sensitivity. Annals of the New York Academy of Sciences 855, 165168.CrossRefGoogle ScholarPubMed
Glick, Z (1981) Modes of action of gallic acid in suppressing food intake of rats. Journal of Nutrition 111, 19101916.CrossRefGoogle ScholarPubMed
Glick, Z, Oku, J & Bray, GA (1982) Effects of polyphenols on food intake and body weight of lean and obese rats. Nutrition and Behavior 1, 7578.Google Scholar
Gloaguen, I, Costa, P, Demartis, A, Lazzaro, D, Di, Marco A, Graziani, R, Paonessa, G, Chen, F, Rosenblum, CI, Van der Ploeg, LH, Cortese, R, Ciliberto, G & Laufer, R (1997) Ciliary neurotrophic factor corrects obesity and diabetes associated with leptin deficiency and resistance. Proceedings of the National Academy of Sciences USA 94, 64566461.CrossRefGoogle ScholarPubMed
Greenberg, D, McCaffery, J, Potack, JZ, Bray, GA & York, DA (1999) Differential satiating effects of fats in the small intestine of obesity-resistant and obesity-prone rats. Physiology and Behavior 66, 621626.CrossRefGoogle ScholarPubMed
Grujic, D, Susulic, VS, Harper, ME, Himms-Hagen, J, Cunningham, BA, Corkey, BE & Lowell, BB (1997) β3-adrenergic receptors on white and brown adipocytes mediate β3-selective agonist-induced effects on energy expenditure, insulin secretion, and food intake. Journal of Biological Chemistry 272, 1768617693.CrossRefGoogle Scholar
Gutzwiller, JP, Drewe, J, Hildebrand, P, Lauper, JZ & Beglinger, C (1994) Effect of intravenous human gastrin-releasing peptide on food intake in humans. Gastroenterology 106, 11681173.CrossRefGoogle ScholarPubMed
Halaas, JL, Gajiwala, KS, Maffei, M, Cohen, SL, Chait, BT, Rabinowitz, D, Lallone, RL, Burley, SK & Friedman, JM (1995) Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269, 543546.CrossRefGoogle ScholarPubMed
Hamamura, M, Leng, G, Emson, PC & Kiyama, H (1991) Electrical activation and c-fos mRNA expression in rat neurosecretory neurons after systemic administration of cholecystokinin. Journal of Physiology 444, 5156.CrossRefGoogle ScholarPubMed
Henke, BR, Willson, TM, Sugg, EE, Croom, DK, Dougherty, RW, Queen, KL, Birkemo, LS, Ervin, GN, Grizzle, MK & Johnson, MF (1996) 3-(1 H-indazol-3-ylmethyl)-1, 5-benzodiazepines: CCK-A agonists that demonstrate oral activity as satiety agents. Journal of Medicinal Chemistry 39, 26552658.CrossRefGoogle Scholar
Herzig, KH, Schon, I, Tatemoto, K, Ohe, Y, Li, Y, Folsch, UR & Owyang, C (1996) Diazepam binding inhibitor is a potent cholecystokinin-releasing peptide in the intestine. Proceedings of the National Academy of Sciences USA 93, 79277932.CrossRefGoogle ScholarPubMed
Heymsfield, SB, Greenberg, AS, Fujioka, K, Dixon, RM, Kushner, R, Hunt, T, Lubina, JA, Patane, J, Self, B, Hunt, P & McCamish, M (1999) Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. Journal of the American Medical Association 282, 15681575.CrossRefGoogle ScholarPubMed
Hoppener, JW, Verbeek, JS, de Koning, EJ, Oosterwijk, C, van Hulst, KL, Visser-Vernooy, HJ, Hofhuis, FM, van Gaalen, S, Berends, MJ & Hackeng, WH (1993) Chronic overproduction of islet amyloid polypeptide/amylin in transgenic mice: lysosomal localization of human islet amyloid polypeptide and lack of marked hyperglycemia or hyperinsulinemia. Diabetologia 36, 12581265.CrossRefGoogle ScholarPubMed
Horn, CC & Friedman, MI (1998) Methylpalmoxirate increases eating behavior and brain fos-like immunoreactivity in rats. Brain Research 781, 814.CrossRefGoogle Scholar
Inoue, S, Nagase, H, Satoh, S, Saito, M, Egawa, M, Tanaka, K & Takamura, Y (1991) Role of the efferent and afferent vagus nerve in the development of ventromedial hypothalamic (VMH) obesity. Brain Research Bulletin 27, 511515.CrossRefGoogle ScholarPubMed
Johnson, MF, Birkemo, LS & Ervin, GN (1994) Chronic administration of cholecystokinin octapeptide (CCK-8) and the cholecystokinin tetrapeptide analogue A71623 decrease the food intake and body weight of restricted-feeder rats. Appetite 23, 309310.Google Scholar
Kirkham, TC, Gibbs, J, Smith, GP & Geary, N (1995a) Meal pattern analysis in rats reveals partial agonist activity of the bombesin receptor antagonist BW2258U89. Pharmacology Biochemistry and Behavior 52, 101106.CrossRefGoogle ScholarPubMed
Kirkham, TC, Perez, S & Gibbs, J (1995b) Prefeeding potentiates anorectic actions of neuromedin B and gastrin releasing peptide. Physiology and Behavior 58, 11751179.CrossRefGoogle ScholarPubMed
Kissileff, HR, Pi-Sunyer, FX, Thornton, J & Smith, GP (1981) C terminal octapeptide of cholecystokinin decreases food intake in man. American Journal of Clinical Nutrition 34, 154160.CrossRefGoogle ScholarPubMed
Klebig, M, Willeinson, JE & Woychik, RP (1994) Molecular analysis of the mouse agouti gene and the role of dominant agouti-locus mutations in obesity and insulin resistance. In Pennington Center Nutrition Series, Vol. 5, Molecular and Genetic Aspects of Obesity, pp. 120158 [Bray, GA and Ryan, DH, editors] Baton Rouge, LA: Louisiana State University Press.Google Scholar
Ladenheim, EE, Moore, KA, Salorio, CF, Mantey, SA, Taylor, JE, Coy, DH, Jensen, RT & Moran, TH (1997a) Characterization of bombesin binding sites in the rat stomach. European Journal of Pharmacology 319, 245251.CrossRefGoogle ScholarPubMed
Ladenheim, EE, Taylor, JE, Coy, DH, Carrigan, TS, Wohn, A & Moran, TH (1997b) Caudal hindbrain neuromedin B-preferring receptors participate in the control of food intake. American Journal of Physiology 272, R433-R437.Google ScholarPubMed
Ladenheim, EE, Taylor, JE, Coy, DH, Moore, KA & Moran, TH (1996a) Hindbrain GRP receptor blockade antagonizes feeding suppression by peripherally administered GRP. American Journal of Physiology 271, R180-R184.Google ScholarPubMed
Ladenheim, EE, Wirth, KE & Moran, TH (1996b) Receptor subtype mediation of feeding suppression by bombesin-like peptides. Pharmacology Biochemistry and Behavior 54, 705711.CrossRefGoogle ScholarPubMed
Langhans, W (1996) Role of the liver in the metabolic control of eating: What we know and what we do not know. Neuroscience Bulletin 20, 145153.Google Scholar
Langhans, W, Delprete, E & Scharrer, E (1991) Mechanisms of vasopressin's anorectic effect. Physiology and Behavior 49, 169176.CrossRefGoogle ScholarPubMed
Langhans, W, Egli, G & Scharrer, E (1985) Selective hepatic vagotomy eliminates the hypophagic effect of different metabolites. Journal of the Autonomic Nervous System 13, 255262.CrossRefGoogle ScholarPubMed
Lee, MC, Schiffman, SS & Pappas, TN (1994) Role of neuropeptides in the regulation of feeding behavior: a review of cholecystokinin, bombesin, neuropeptide Y, and galanin. Neuroscience and Biobehavioral Reviews 18, 313323.CrossRefGoogle ScholarPubMed
Leibowitz, SF & Hoebel, BG (1998) Behavioral neuroscience of obesity. In Handbook of Obesity, pp. 313358 [Bray, GA, Bouchard, C and James, WPT, editors]. New York: Marcel Dekker Inc.Google Scholar
Levine, AS & Morley, JE (1981) Reduction of feeding in rats by calcitonin. Brain Research 222, 187191.CrossRefGoogle ScholarPubMed
Liddle, RA (1995) Regulation of cholecystokinin secretion by intraluminal releasing factors. American Journal of Physiology 269, G319-G327.Google ScholarPubMed
Lieverse, RJ, Jansen, JB, Masclee, AA & Lamers, CB (1995a) Satiety effects of a physiological dose of cholecystokinin in humans. Gut 36, 176179.CrossRefGoogle ScholarPubMed
Lieverse, RJ, Jansen, JB, Masclee, AM & Lamers, CB (1995b) Effects of somatostatin on human satiety. Neuroendocrinology 61, 112116.CrossRefGoogle ScholarPubMed
Lieverse, RJ, Jansen, JBMJ, de Zwan, A, Samson, L, Masclee, AA, Rovati, LC & Lamers, CB (1993) Bombesin reduces food intake in lean man by a cholecystokinin-independent mechanism. Journal of Clinical Endocrinology and Metabolism 76, 14951498.Google Scholar
Lieverse, RJ, Masclee, AA, Jansen, JB, Lam, WF & Lambers, CB (1998) Obese women are less sensitive for the satiety effects of the bombesin than lean women. European Journal of Clinical Nutrition 52, 207212.CrossRefGoogle ScholarPubMed
Lieverse, RJ, Masclee, AA, Jansen, JB, Rovati, LC & Lamers, CB (1995c) Satiety effects a type A CCK receptor antagonist loxiglumide in lean and obese women. Biological Psychiatry 37, 331335.CrossRefGoogle ScholarPubMed
Lin, L, Okada, S, York, DA & Bray, GA (1994) Structural requirements for the biological activity of enterostatin. Peptides 15, 849854.CrossRefGoogle ScholarPubMed
Lin, L, Umahara, M, York, DA & Bray, GA (1998) b-casomorphins stimulate and enterostatin inhibits the intake of dietary fat in rats. Peptides 19, 325331.CrossRefGoogle Scholar
Lin, L & York, DA (1995) Feeding responses after microinjection of enterostatin into the PVN and amygdala. Obesity Research 3, 412S Abstr.Google Scholar
Lin, L & York, DA (1998) Chronic ingestion of dietary fat is a prerequisite for inhibition of feeding by enterostatin. American Journal of Physiology 275, R619-R623.Google ScholarPubMed
Lotter, EC, Krinsky, R, McKay, JM, Treneer, CM, Porte, D Jr & Woods, SC (1981) Somatostatin decreases food intake of rats and baboons. Journal of Comparative Physiology and Psychology 5, 278287.CrossRefGoogle Scholar
Louis-Sylvestre, J & Le Magnen, J (1980) A fall in blood glucose level precedes meal onset in free-feeding rats. Neuroscience and Behavior Reviews 4, 1315.CrossRefGoogle ScholarPubMed
Lunetta, M, Di Mauro, M, Le Moli, R & Burafato, S (1996) Long-term octreotide treatment reduced hyperinsulinemia, excess body weight and skin lesions in severe obesity with acanthosis nigricans. Journal of Endocrinological Investigation 19, 699703.CrossRefGoogle ScholarPubMed
Lustig, RH, Rose, SR, Burghen, GA, Velasquez-Mieyer, P, Broome, DC, Smith, K, Li, H, Hudson, MM, Heideman, RL & Kun, LE (1999) Hypothalamic obesity caused by cranial insult in children: altered glucose insulin dynamics and reversal by a somatostatin agonist. Journal of Pediatrics 135, 162168.CrossRefGoogle ScholarPubMed
Lutz, TA, Geary, N, Szabady, MM, Del, Prete E & Scharrer, E (1995) Amylin decreases meal size in rats. Physiology and Behavior 58, 11971202.CrossRefGoogle ScholarPubMed
McGaowan, MK, Andrews, KN, Fenner, D & Grossman, SP (1993) Chronic introhypothalamine insulin infusion in the rat: behavioral specificity. Physiology and Behavior 54, 10311034.CrossRefGoogle Scholar
Matsumoto, I, Oomura, Y, Nishino, H, Nemoto, S, Aou, S & Aikawa, T (1994) Effects of 2-buten-4-olide, an endogenous satiety substance, on plasma glucose, corticosterone, and catecholamines. American Journal of Physiology 266, R413-R418.Google ScholarPubMed
Mayer, J (1953) Glucostatic mechanism of regulation of food intake. New England Journal of Medicine 249, 1316.CrossRefGoogle ScholarPubMed
Miyasaka, K & Funakoshi, A (1997) Stimulatory effect of synthetic luminal cholecystokinin releasing factor (LCRF) fragment (1–35) on pancreatic exocrine secretion in conscious rats. Pancreas 15, 310313.CrossRefGoogle ScholarPubMed
Montague, CT, Farooqi, S, Whitehead, JP, Soos, MA, Rau, H, Wareham, NJ, Sewter, CP, Digby, JE, Mohammed, SN, Hurst, JA, Cheetham, CH, Earley, AR, Barnett, AH, Prins, JB & O'Rahilly, S (1997) Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387, 903908.CrossRefGoogle ScholarPubMed
Moran, TH, Katz, LF, Plata-Salaman, CR & Schwartz, GJ (1998) Disordered food intake and obesity in rats lacking cholecystokinin A receptor. American Journal of Physiology 274, R618-R625.Google Scholar
Moran, TH, Sawyer, TK, Seeb, DH, Ameglio, PJ, Lombard, MA & McHugh, PR (1992) Potent and sustained satiety actions of a cholecystokinin octapeptide analogue. American Journal of Clinical Nutrition 55, S286S290.CrossRefGoogle ScholarPubMed
Morley, JE, Flood, JF, Horowitz, M, Morley, PM & Walter, MJ (1994) Modulation of food intake by peripherally administered amylin. American Journal of Physiology 267, R178-R184.Google ScholarPubMed
Morley, JE, Levine, AS, Brown, DM & Handwerger, BS (1982) The effect of calcitonin on food intake in diabetic mice. Peptides 3, 1720.CrossRefGoogle ScholarPubMed
Muurahainen, NE, Kissileff, HR & Pi-Sunyer, FX (1993) Intravenous infusion of bombesin reduces food intake in humans. American Journal of Physiology 264, R350R354.Google ScholarPubMed
Nagase, H, Bray, GA & York, DA (1996a) Pyruvate and hepatic pyruvate dehydrogenase levels in rat strains sensitive and resistant to dietary obesity. American Journal of Physiology 270, R489-495.Google ScholarPubMed
Nagase, H, Bray, GA & York, DA (1996b) Effects of pyruvate and lactate on food intake in rat strains sensitive and resistant to dietary obesity. Physiology and Behavior 59, 555560.CrossRefGoogle ScholarPubMed
Nagase, H, Bray, GA & York, DA (1996c) Effect of galanin and enterostatin on sympathetic-nerve activity to interscapular brown adipose-tissue. Brain Research Bulletin 709, 4450.CrossRefGoogle ScholarPubMed
Nauck, MA, Heimesaat, MM, Orskov, C, Holst, JJ, Ebert, R & Creutzfeldt, W (1993) Preserved incretion activity of glucagon-like peptide 1 [7–36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. Journal of Clinical Investigation 91, 301307.CrossRefGoogle Scholar
Niijima, A (1983) Glucose-sensitive afferent nerve fibers in the liver and their role in food intake and blood glucose regulation. Journal of the Autonomic Nervous System 9, 207220.CrossRefGoogle ScholarPubMed
Ogawa, Y, Masuzaki, H, Sagawa, N & Nakao, K (1999) Leptin as an adipocyte- and nonadipocyte-derived hormone. In Pennington Center Nutrition Series Vol. 9, Nutrition, Genetics, and Obesity, pp. 147155[Bray, GA and Ryan, DH, editors]. Baton Rouge, LA: Louisiana State University Press.Google Scholar
Okada, S, York, DA, Bray, GA & Erlanson-Albertsson, C (1991) Enterostatin, (Val-Pro-Asp-Pro-Arg), the activation peptide of procolipase selectivity reduces fat intake. Physiology and Behavior 49, 11851189.CrossRefGoogle ScholarPubMed
Okki-Hamazaki, H, Watase, K, Yamamoto, K, Ogura, H, Yamano, M, Yamada, K, Maeno, H, Imaki, J, Kikuyama, S, Wada, E & Wada, K (1997) Mice lacking bombesin receptor subtype-3 develop metabolic defects and obesity. Nature 390, 165167.CrossRefGoogle Scholar
Okumura, T, Fukagawa, K, Tso, P, Taylor, IL & Pappas, TN (1995) Mechanism of action of intracisternal apolipoprotein A-IV in inhibiting gastric acid secretion in rats. Gastroenterology 109, 15831588.CrossRefGoogle ScholarPubMed
Oomura, Y (1986) Feeding regulation by endogenous sugar acids through hypothalamic chemosensitive neurons. Brain Research Bulletin 17, 551562.CrossRefGoogle ScholarPubMed
Orthen-Gambill, N & Kanarek, RR (1982) Differential effects of amphetamine and fenfluramine on dietary self-selection in rats. Pharmacology 16, 303309.Google ScholarPubMed
Pelleymounter, MA, Cullen, MJ, Baker, MB, Hecht, R, Winters, D, Boone, T & Collins, F (1995) Effects of the obese gene-product on body-weight regulation in OB/OB mice. Science 269, 540543.CrossRefGoogle ScholarPubMed
Penick, SB & Hinkle, L (1961) Depression of food intake induced in healthy subjects by glucagon. New England Journal of Medicine 264, 893898.CrossRefGoogle ScholarPubMed
Pieber, TR, Roitelman, J, Lee, Y, Luskey, KL & Stein, DT (1994) Direct plasma radioimmunoassay for rat amylin-(1–37): concentrations with acquired and genetic obesity. American Journal of Physiology 267, E156-E164.Google ScholarPubMed
Porte, D Jr, Seeley, RJ, Woods, SC, Baskin, DG, Figlewicz, DP & Schwartz, MW (1998) Obesity, diabetes and the central nervous system. Diabetologia 41, 863881.CrossRefGoogle ScholarPubMed
Ravussin, E & Swinburn, BA (1992) Pathophysiology of obesity. Lancet 340, 404408.CrossRefGoogle ScholarPubMed
Rice, HB & Corwin, RL (1998) Effects of enterostatin on consumption of optional foods in non-food-deprived rats. Obesity Research 6, 5461.CrossRefGoogle ScholarPubMed
Ritter, S, Calingasan, NY, Hutton, B & Dinh, TT (1992) Cooperation of vagal and central neural systems in monitoring metabolic events controlling feeding behavior in neuroanatomy and physiology of abdominal vagal afferents. In Neuroanatomy and Physiology of Abdominal Vagal Efferent, pp. 249277 [Ritter, S, Ritter, RC and Barnes, CD, editors]. Boca Raton, FL: CRC Press.Google Scholar
Ritter, S & Taylor, JS (1989) Capsaicin abolishes lipoprivic but not glucoprivic feeding in rats. American Journal of Physiology 256, R1232-R1239.Google Scholar
Ritter, S & Taylor, JS (1990) Vagal sensory neurons are required for lipoprivic but not glucoprivic feeding in rats. American Journal of Physiology 258, R1395-R1401.Google Scholar
Rossner, S, Barkeling, B, Erlanson-Albertsson, C, Larsson, P & Wahlin-Boll, E (1995) Intravenous enterostatin does not affect single meal food intake in man. Appetite 34, 3742.CrossRefGoogle Scholar
Rushing, PA, Gibbs, J & Geary, N (1996) Brief, meal-contingent infusions of gastrin-releasing peptide 1–27 and neuromedin B-10 inhibit spontaneous feeding in rats. Physiology and Behavior 60, 15011504.CrossRefGoogle ScholarPubMed
Russek, M (1963) A hypothesis on the participation of hepatic glucoreceptors in the control of food intake. Nature 197, 7980.CrossRefGoogle Scholar
Sakata, T & Kurokawa, M (1992) Feeding modulation by pentose and hexose analogues. American Journal of Clinical Nutrition 55, 272S277S.CrossRefGoogle ScholarPubMed
Sakata, T, Terada, K, Arase, K, Fujimoto, K, Oomura, Y, Okukado, N & Uchikawa, O (1989) Stereospecific feeding modulation by endogenous organic acid gamma-lactone in rats. American Journal of Physiology 256, R366-R370.Google ScholarPubMed
Schulman, JL, Carleton, JL, Whitney, E & Whitehorn, JC (1957) Effect of glucagon on food intake and body weight in man. Journal of Applied Physiology 11, 419421.CrossRefGoogle ScholarPubMed
Schwartz, MW, Boyko, EJ, Kahn, SE, Ravussin, E & Bogardus, C (1995) Reduced insulin-secretion: An independent predictor of body weight gain. Journal of Clinical Endocrinology 80, 15711576.Google ScholarPubMed
Schwartz, MW, Figlewicz, DP, Baskin, DG, Woods, SC & Porte D, Jr (1994) Insulin in the brain: A hormonal regulator of energy balance. Endocrine Reviews 13, 387414.Google Scholar
Shargill, NS, Tsujii, S, Bray, GA & Erlanson-Albertsson, C (1991) Enterostatin suppresses food intake following injection into the third ventricle of rats. Brain Research 544, 137140.CrossRefGoogle ScholarPubMed
Shimizu, H, Shargill, NS, Bray, GA, Yen, TT & Gesellechen, PD (1989) Effects of MSH on food intake, body weight and coat color of the yellow obese mouse. Life Sciences 45, 543552.CrossRefGoogle ScholarPubMed
Silverstone, PH, Oldman, D, Johnson, B & Cowen, PJ (1992) Ondansetron, a 5-HT3 receptor antagonist, partially attenuates the effects of amphetamine: a pilot study in healthy volunteers. International Clinical Psychopharmacology 7, 3743.CrossRefGoogle Scholar
Singer, LK, York, DA & Bray, GA (1997) Feeding response to mercaptoacetate in Osborne-Mendel and S5B/PL rats. Obesity Research 5, 587594.CrossRefGoogle ScholarPubMed
Smith, GP & Gibbs, J (1994) Satiating effect of cholecystokinin. Annals of the New York Academy of Sciences 713, 236241.CrossRefGoogle ScholarPubMed
Smith, GP, Jerome, C & Gibbs, J (1981) Abdominal vagotomy does not block the satiety effect of bombesin in the rat. Peptides 2, 409411.CrossRefGoogle Scholar
Sorhede, M, Erlanson-Albertsson, C, Mei, J, Nevalainen, T, Aho, A & Sundler, F (1996) Enterostatin in gut endocrine cells – immunocytochemical evidence. Peptides 17, 609614.CrossRefGoogle ScholarPubMed
Stacher, G, Steinringer, H, Schmierer, G, Schneider, C & Winklehner, S (1982) Cholecystokinin octapeptide decreases intake of solid food in man. Peptides 1, 133136.CrossRefGoogle Scholar
Stein, LJ & Woods, SC (1983) GRP reduces meal size in rats. Peptides 3, 833835.CrossRefGoogle Scholar
Stricker, EM & Rowland, N (1978) Hepatic versus cerebral origin of stimulus for feeding induced by 2-deoxy-D-glucose in rats. Journal of Comparative Physiology and Psychology 92, 126132.CrossRefGoogle ScholarPubMed
Sundaresan, PR, Weintraub, M, Hershey, LA, Kroening, BH, Hasday, JD & Banerjee, SP (1983) Platelet alpha-adrenergic receptors in obesity: Alteration with weight loss. Clinical Pharmacology and Therapeutics 33, 776785.CrossRefGoogle ScholarPubMed
Susulic, VS, Frederic, RC, Lawitts, J, Tozzo, E, Kahn, BB, Harper, ME, Himms-Hagen, J, Flier, JS & Lowell, BB (1995) Targeted disruption of the b(3) adrenergic receptor gene. Journal of Biological Chemistry 270, 94839492.CrossRefGoogle Scholar
Terada, K, Sakata, T, Oomura, Y, Fujimoto, K, Arase, K, Osanai, T & Nagai, Y (1986) Hypophagia induced by endogenous or liposome-encapsulated 3,4-dihydroxybutanoic acid. Physiology and Behavior 38, 861869.CrossRefGoogle ScholarPubMed
Thompson, DA & Campbell, RG (1977) Hunger in man induced by 2-deoxy-D-glucose: glucoprivic control of taste preference and food intake. Science 198, 10651068.CrossRefGoogle ScholarPubMed
Tian, Q, Nagase, H, York, DA & Bray, GA (1994) Vagal-central nervous system interactions modulate the feeding responses to peripheral enterostatin. Obesity Research 2, 527534.CrossRefGoogle ScholarPubMed
Tordoff, MG, Rawson, N & Friedman, MI (1991) 2,5-Anhydro-D-mannitol acts in liver to initiate feeding. American Journal of Physiology 261, R283-R288.Google Scholar
Tsujii, S & Bray, GA (1992) Food intake of lean and obese Zucker rats following ventricular infusions of adrenergic agonists. Brain Research 587, 226232.CrossRefGoogle ScholarPubMed
Tsujii, S & Bray, GA (1998) b3 Adrenergic agonist (BRL-37344) decreases food intake. Physiology and Behavior 63, 723728.CrossRefGoogle Scholar
United Kingdom Prospective Diabetes Study Group (1998) United Kingdom Prospective Diabetes Study 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. Annals of Internal Medicine 128, 165175.CrossRefGoogle Scholar
VanderWeele, DA, Harackiewicz, E & Van Itallie, TB (1982) Elevated insulin and satiety in obese and normal weight rats. Appetite 3, 99109.CrossRefGoogle ScholarPubMed
Woods, SC, Lotter, EC, McKay, LD & Porte, D (1979) Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons. Nature 282, 503505.CrossRefGoogle ScholarPubMed
Yamashita, J, Onai, T, York, DA & Bray, GA (1994) Relationship between food intake and metabolic rate in rats treated with β-adrenergic agonists. International Journal of Obesity 18, 429433.Google Scholar
Yoshimatsu, H, Egawa, M & Bray, GA (1992) Effects of cholecystokinin on sympathetic activity to interscapular brown adipose tissue. Brain Research 597, 298303.CrossRefGoogle ScholarPubMed
Zhang, Y & Leibel, RL (1998) Molecular physiology of leptin and its receptor. Growth, Genetics and Hormones 14, 1726.Google Scholar
Zhang, Y, Proenca, R, Maffei, M, Barone, M, Leopold, L & Friedman, M (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425432.CrossRefGoogle ScholarPubMed